How Arizona is Poised to Become a Major Player in Psychedelic Therapy Research. @AZBIGMEDIA

Arizona is poised to become a major hub for psychedelic therapy research, thanks to a new bill introduced in the state’s 2023-2024 budget bill in May. The provision will provide $5 million in funding for studies on the medical benefits of psilocybin and other psychedelic substances at Arizona universities and research centers.


Related Articles
Ketamine-Assisted Therapy as an Employee Benefit

“Investing in the mental health of employees is absolutely crucial. Daytryp is proud to partner with Enthea to help future-thinking employers offer Ketamine Therapy which have long lasting, transformative outcomes,” said Chris Cohn, CEO of Daytryp Health.

Meet Chris Cohn, Founder of Daytryp

Chris Cohn is passionate about health and wellness, though by his own admission, he has traveled a less-than-conventional road to get to where he is today. The Phoenix native founded Scottsdale Recovery Center and Arizona Addiction Center in 2009. And just last year, he opened Daytryp Health Center in Arcadia.